JP Stock MarketDetailed Quotes
190A Chordia Therapeutics
- 172
- -14-7.53%
20min DelayNot Open Jun 28 15:00 JST
11.27BMarket Cap-6336P/E (Static)
194High169Low2.69MVolume191Open186Pre Close485.18MTurnover25752wk High47.69%Turnover Ratio65.54MShares14252wk Low-27.143EPS TTM969.62MFloat Cap257Historical HighLossP/E (Static)5.64MShs Float142Historical Low-27.143EPS LYR13.44%Amplitude--Dividend TTM2.24P/B100Lot Size--Div YieldTTM
About Chordia Therapeutics Company
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.
Company Profile
Symbol190A
Company NameChordia Therapeutics
MarketTSE Growth
Address2-26-1 Muraoka-Higashi Kanagawa
Company Executives
- Name
- Position
- Salary
- Hiroshi Miyake
- Representative Director
- --
- Yukari Nishikata
- Independent Director
- --
- Kousuke Ishii
- Independent Director
- --
- Ayuko Hashimoto
- Independent Director
- --
- Akihiko Shimauchi
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
JP
Overall
Symbol
Latest Price
%Chg